• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探索巴西的甲状腺眼病:一项单中心研究的见解

Exploring thyroid eye disease in Brazil: insights from a single-center study.

作者信息

Villagelin Danilo, Perini Nicolas, Santos Roberto Bernardo, Romaldini João Hamilton

机构信息

Pontifícia Universidade Católica de Campinas Escola de Ciências da Vida Faculdade de Medicina Campinas SP Brasil Pontifícia Universidade Católica de Campinas, Escola de Ciências da Vida, Faculdade de Medicina, Campinas, SP, Brasil.

Universidade Estadual de Campinas Campinas SP Brasil Universidade Estadual de Campinas, Pós-graduação em Medicina Interna, Campinas, SP, Brasil.

出版信息

Arch Endocrinol Metab. 2025 Aug 20;69(3):e240495. doi: 10.20945/2359-4292-2024-0495.

DOI:10.20945/2359-4292-2024-0495
PMID:40834360
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12367249/
Abstract

OBJECTIVE

Graves' disease (GD) is the leading cause of hyperthyroidism globally, with 40% of affected individuals developing thyroid eye disease (TED). Treatment options for TED have advanced in recent years. This study aimed to investigate the prevalence of TED at a single center in Brazil, contributing more robust data for cost-analysis studies assessing the financial implications of novel TED treatments. Subjects and.

METHODS

This study evaluated the clinical histories of 660 patients diagnosed with GD from 1999 to 2019. The patients were categorized into four groups based on the presence and severity of TED.

RESULTS

The prevalence of TED within the study population, categorized according to severity, was as follows: absent (n = 325; 49%), mild (n = 221; 33%), moderate to severe (n = 107; 16%), and sight-threatening (n = 7; 1%). A significant correlation was observed between older age at diagnosis, smoking, larger goiters, and the presence and severity of TED.

CONCLUSION

The prevalence of TED identified in this single-center study contributes valuable insights for the design of cost-analysis studies and the assessment of the financial implications of novel treatments for TED within both the public and private healthcare systems in Brazil.

摘要

目的

格雷夫斯病(GD)是全球甲状腺功能亢进的主要原因,40%的患者会发展为甲状腺眼病(TED)。近年来,TED的治疗选择有了进展。本研究旨在调查巴西一个单一中心的TED患病率,为评估新型TED治疗的财务影响的成本分析研究提供更有力的数据。对象与方法:本研究评估了1999年至2019年期间660例诊断为GD的患者的临床病史。根据TED的存在情况和严重程度将患者分为四组。结果:根据严重程度分类,研究人群中TED的患病率如下:无(n = 325;49%)、轻度(n = 221;33%)、中度至重度(n = 107;16%)和威胁视力(n = 7;1%)。在诊断时年龄较大、吸烟、甲状腺肿较大与TED的存在和严重程度之间观察到显著相关性。结论:在这项单中心研究中确定的TED患病率为巴西公共和私营医疗系统中成本分析研究的设计以及新型TED治疗的财务影响评估提供了有价值的见解。

相似文献

1
Exploring thyroid eye disease in Brazil: insights from a single-center study.探索巴西的甲状腺眼病:一项单中心研究的见解
Arch Endocrinol Metab. 2025 Aug 20;69(3):e240495. doi: 10.20945/2359-4292-2024-0495.
2
Thyroid eye disease (Graves' orbitopathy): clinical presentation, epidemiology, pathogenesis, and management.甲状腺眼病(格雷夫斯眶病):临床表现、流行病学、发病机制及管理
Lancet Diabetes Endocrinol. 2025 Jul;13(7):600-614. doi: 10.1016/S2213-8587(25)00066-X. Epub 2025 May 2.
3
Clinical Features of Chinese Patients with Thyroid Eye Disease: A Multicenter Retrospective Study.中国甲状腺眼病患者的临床特征:一项多中心回顾性研究。
Thyroid. 2025 Aug 11. doi: 10.1177/10507256251359559.
4
Statins and thyroid eye disease (TED): a systematic review.他汀类药物与甲状腺眼病(TED):一项系统综述。
Endocrine. 2024 Jul;85(1):11-17. doi: 10.1007/s12020-023-03680-5. Epub 2024 Jan 9.
5
Thyroid surgery for Graves' disease and Graves' ophthalmopathy.用于治疗格雷夫斯病和格雷夫斯眼病的甲状腺手术。
Cochrane Database Syst Rev. 2015 Nov 25;2015(11):CD010576. doi: 10.1002/14651858.CD010576.pub2.
6
Clinical study of thyroid eye disease combined with myasthenia gravis.甲状腺眼病合并重症肌无力的临床研究
Jpn J Ophthalmol. 2025 May 5. doi: 10.1007/s10384-025-01208-0.
7
The Epidemiology of Thyroid Eye Disease in Olmsted County, Minnesota, 2005-2020.明尼苏达州奥姆斯特德县2005 - 2020年甲状腺眼病的流行病学情况
Thyroid. 2024 Dec;34(12):1522-1530. doi: 10.1089/thy.2024.0304. Epub 2024 Oct 7.
8
Iran Thyroid Eye Disease (IrTED) Registry: Patient Characteristics and Clinical Presentation.伊朗甲状腺眼病(IrTED)登记处:患者特征与临床表现
Semin Ophthalmol. 2025 Jul;40(5):412-418. doi: 10.1080/08820538.2025.2463946. Epub 2025 Feb 9.
9
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
10
Cigarette smoking and thyroid eye disease: a systematic review.吸烟与甲状腺眼病:一项系统综述。
Eye (Lond). 2007 Sep;21(9):1135-45. doi: 10.1038/sj.eye.6702603. Epub 2006 Sep 15.

本文引用的文献

1
A Review of Novel Medical Treatments for Thyroid Eye Disease.甲状腺眼病新型医学治疗方法综述
Korean J Ophthalmol. 2024 Jun;38(3):249-259. doi: 10.3341/kjo.2024.0031. Epub 2024 May 22.
2
The changing landscape of thyroid eye disease: current clinical advances and future outlook.甲状腺眼病的变化格局:当前临床进展及未来展望。
Eye (Lond). 2024 Jun;38(8):1425-1437. doi: 10.1038/s41433-024-02967-9. Epub 2024 Feb 19.
3
The genetics of Graves' disease.格雷夫斯病的遗传学。
Rev Endocr Metab Disord. 2024 Feb;25(1):203-214. doi: 10.1007/s11154-023-09848-8. Epub 2023 Dec 18.
4
Hyperthyroidism: A Review.甲状腺功能亢进症:综述。
JAMA. 2023 Oct 17;330(15):1472-1483. doi: 10.1001/jama.2023.19052.
5
Increased Risk of Thyroid Eye Disease Following Covid-19 Vaccination.接种新冠疫苗后患甲状腺眼病的风险增加。
J Clin Endocrinol Metab. 2024 Jan 18;109(2):516-526. doi: 10.1210/clinem/dgad501.
6
Management of thyroid eye disease: a Consensus Statement by the American Thyroid Association and the European Thyroid Association.甲状腺眼病的管理:美国甲状腺协会和欧洲甲状腺协会的共识声明
Eur Thyroid J. 2022 Dec 8;11(6). doi: 10.1530/ETJ-22-0189. Print 2022 Dec 1.
7
Coronavirus as a Trigger Of Graves' Disease.冠状病毒作为格雷夫斯病的诱因
Acta Endocrinol (Buchar). 2021 Jul-Sep;17(3):413-415. doi: 10.4183/aeb.2021.413.
8
The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy.2021 年欧洲 Graves 眼病专家组(EUGOGO)Graves 眼病医学管理临床实践指南。
Eur J Endocrinol. 2021 Aug 27;185(4):G43-G67. doi: 10.1530/EJE-21-0479.
9
Current Knowledge on Graves' Orbitopathy.格雷夫斯眼眶病的当前知识
J Clin Med. 2020 Dec 23;10(1):16. doi: 10.3390/jcm10010016.
10
Prevalence of thyroid eye disease in Graves' disease: A meta-analysis and systematic review.Graves 病伴甲状腺眼病的患病率:Meta 分析和系统评价。
Clin Endocrinol (Oxf). 2020 Oct;93(4):363-374. doi: 10.1111/cen.14296. Epub 2020 Aug 10.